The WHO expressly forbids dual labelling and BME/PVFS (G93.3) is excluded from neurasthenia (F48.0) and vice versa. The WHO coding is binding here, and should be there too. So he probably loses on a legal technicality.
Thankfully it's ticking along though.
Jenny's reference above (the $1K leads to $25K number) is really powerful, and I hope that persuades a few more people to donate.
My thought was that it would tell people to pace and rest. CS made this point at our table, because there will also be clear-cut cases that haven't passed the 4-6 month 'chronic' stage that still need treatment. If people rest early, they may avoid further damage.
Is this an old video? I feel like I've seen it before.
Since then, I think she has addressed the Wessely error. She has had to make the case to the GMC about why he should be included, I think, so someone obviously pointed out he wasn't an author. However, he was involved as a centre...
The CCC and ICC do make a nod to the need to cover both groups of patients by having the possibility of an ME (or ME/CFS) diagnosis, atypical ME and idiopathic chronic fatigue by simply fulfilling more or less of the same set of criteria. So if you lack one or two of the secondary criteria, it's...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.